Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Maria Vadiaka"'
Autor:
Christina Vourlakou, Alexandros Skourtis, Eugenia Grivakou, Maria Vadiaka, Dimitris Kounatidis, Fotis Panagopoulos, Eleni Geladari, Edison Jahaj
Publikováno v:
Journal of Infection and Chemotherapy. 27:1357-1359
Coxiella burnetii is a gram-negative bacterium that typically lives and multiplies within monocytes and macrophages of the host, being the etiologic agent of the zoonosis Q fever. Q fever is usually divided into acute and chronic forms, with a signif
Autor:
Evangelia Margellou, Dimitra Rontogianni, Maria Vadiaka, Georgia Dimopoulou, Andreas Paraskevas, Georgios Kafetzis, Eleni Geladari
Publikováno v:
Cardiovascular & Hematological Disorders-Drug Targets. 20:160-163
Background: :The coexistence of two or more types of lymphoma within the same organ at the same time of diagnosis is defined as composite lymphoma, a rare disease that has recently been identified in the literature. Pointedly, the concurrence may be
Autor:
Maria Vadiaka, Fotis Konstantinou, Dimitrios Sampaziotis, Dimitris Kounatidis, Charikleia Kouvidou, Fotis Panagopoulos, Natalia G. Vallianou, Alexandros Skourtis
Publikováno v:
Rheumatology international. 40(6)
IgA vasculitis, formerly known as Henoch–Schonlein purpura (HSP), is the most common form of systemic vasculitis in children and is characterized by inflammation of the small vessels with typical deposition of IgA immune complexes. It is a leukocyt
Autor:
Spyridon Deftereos, Stamatis Georgopoulos, Antonios Sideris, Maria Vadiaka, Konstantinos P. Letsas, Georgios Giannopoulos, Louiza Lioni, Konstantinos Vlachos, Michael Efremidis
Publikováno v:
Journal of Electrocardiology. 48:840-844
Left atrial ablation for atrial fibrillation (AF) is associated with a transiently increased risk of thromboembolic and hemorrhagic events. We tested the hypothesis that the low dose dabigatran [110mg twice a day (bid)] can be safely used as an alter
Autor:
Sofia Rokana, Dimitris Dimitropoulos, Niki Stavroyianni, Thomas Makatsoris, A. Onyenadum, Christos Kosmas, Evangelos Sepsas, Maria Vadiaka, Haralambos P. Kalofonos, Nicolas Tsavaris
Publikováno v:
International Journal of Cancer. 98:141-147
In an attempt to develop more effective chemotherapy regimens in advanced nonsmall cell lung cancer (NSCLC), we evaluated docetaxel-ifosfamide-cisplatin (DIP) based on our previous experience with paclitaxel-ifosfamide-cisplatin. Patients with advanc
Autor:
C. Panopoulos, M Antonopoulos, N. Malamos, N. Tsavaris, Maria Vadiaka, Christos Kosmas, Niki Stavroyianni, H. P. Kalofonos, Th Kourelis
Publikováno v:
European Journal of Cancer. 37:972-978
Treatment options in patients with recurrent non-small-cell lung cancer (NSCLC) remain limited as a result of the poor activity of older agents after platinum-based therapy. The present phase II study aimed to evaluate the combination of gemcitabine
Autor:
Maria Vadiaka, Christos Kosmas, John Boletis, Theodoros Chiras, Nicolas Tsavaris, Alkis Kostakis
Publikováno v:
Medical Oncology. 18:221-226
A 37-yr-old man who had undergone renal transplantation for end-stage renal failure presented with a large right pelvic mass obstructing the transplanted kidney. Initially, this was diagnosed as an anaplastic tumor while he had been on immunosuppress
Autor:
Haralambos P. Kalofonos, Christos Kosmas, Sofia Rokana, Nicolas Tsavaris, Niki Stavroyianni, Angelos Koutras, Nikolaos A. Malamos, A. Onyenadum, Maria Vadiaka, Aristidis Polyzos
Publikováno v:
Cancer. 92:2902-2910
BACKGROUND Treatment options for patients with recurrent nonsmall cell lung carcinoma (NSCLC) remain limited as a result of poor activity of older agents after platinum-based therapy. In the current Phase II study, the authors evaluated the combinati
Autor:
Evangelos Sepsas, Nikolaos A. Malamos, Haralambos P. Kalofonos, Aristidis Polyzos, Minas J. Antonopoulos, Maria Vadiaka, Christos Kosmas, Nicolas B. Tsavaris, Theodosios Dosios
Publikováno v:
Cancer. 89:774-782
BACKGROUND The necessity to develop more effective chemotherapy regimens in advanced nonsmall cell lung carcinoma (NSCLC) prompted the authors to evaluate the paclitaxel-ifosfamide-cisplatin (PIC) combination, developed on the basis of high individua
Autor:
Dimitrios Manolatos, Fotios Kardaras, Gerasimos Filippatos, Antonios Sideris, Michalis Efremidis, Konstantinos P. Letsas, Gerasimos Gavrielatos, Constantinos Mihas, Maria Vadiaka, Ioannis P. Alexanian, Loukas K. Pappas, Dimitrios Oikonomou
Background Limited data are available on the predictors of atrial fibrillation (AF) recurrence in patients with chronic AF. Objectives To evaluate potential clinical, echocardiographic and electrophysiological predictors of AF recurrence after intern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a8d72203fa3f73030fb7e1591cd0eb
https://europepmc.org/articles/PMC2706771/
https://europepmc.org/articles/PMC2706771/